897 filings
Page 9 of 45
424B5
eka1cdgzc
1 Nov 23
Prospectus supplement for primary offering
7:51am
4
bvqmdnojlas
24 Oct 23
Apellis Pharmaceuticals / James George Chopas ownership change
4:20pm
4
mxx5e8k4 qt
24 Oct 23
Apellis Pharmaceuticals / Mark Jeffrey DeLong ownership change
4:18pm
144
dmxaldtxzk fde28oz
23 Oct 23
Notice of proposed sale of securities
3:37pm
144
ulu13 mjvdxev6
23 Oct 23
Notice of proposed sale of securities
3:27pm
4
88ppw uteaseblh
18 Oct 23
Apellis Pharmaceuticals / Alec Machiels ownership change
5:43pm
144
ltuh33drtgy319uwdgu9
17 Oct 23
Notice of proposed sale of securities
10:54am
4
31lpy0 ofemu79
10 Oct 23
Apellis Pharmaceuticals / Pascal Deschatelets ownership change
4:26pm
144/A
csi1gdru
10 Oct 23
Notice of proposed sale of securities (amended)
9:30am
144
o2rpo1tk e59q
10 Oct 23
Notice of proposed sale of securities
8:29am
8-K
e4rhsytx hpipdd9vnv
5 Oct 23
Apellis Announces Preliminary U.S. Net Revenues of Approximately $74 Million for SYFOVRE® (pegcetacoplan injection) in the Third Quarter of 2023
7:15am
4
exix 562a8nrts
20 Sep 23
Apellis Pharmaceuticals / Cedric Francois ownership change
4:26pm
4
qnm95b0h6lk3
19 Sep 23
Apellis Pharmaceuticals / Alec Machiels ownership change
5:05pm
4
5rxxp502ywzn
19 Sep 23
Apellis Pharmaceuticals / Nur Nicholson ownership change
5:03pm
4
zqlqq6 syci
18 Sep 23
Apellis Pharmaceuticals / Alec Machiels ownership change
4:24pm
4
yg6gibhl
18 Sep 23
Apellis Pharmaceuticals / James George Chopas ownership change
4:20pm
144
egq7aa
18 Sep 23
Notice of proposed sale of securities
3:16pm
144
g78y70by
18 Sep 23
Notice of proposed sale of securities
2:21pm
144
ydy24tqa o0
15 Sep 23
Notice of proposed sale of securities
12:12pm